VIVO CAPITAL, LLC Celldex Therapeutics, Inc. Transaction History

VIVO CAPITAL, LLC portfolio value:

$5.59M
portfolio value

VIVO CAPITAL, LLC quarter portfolio value change:

+4.27%
quarter

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -64.38% -359.65K shares -9.46M $28.11 198.98K
Q2 2022 share Decrease -11.10% -69.72K shares -6.34M $26.96 558.63K
Q1 2022 share Increase +29.70% 143.90K shares 2.68M $34.06 628.35K
Q4 2021 share 0.00% 0 shares -7.43M $38.9 484.45K
Q3 2021 share Decrease -50.00% -484.45K shares -6.24M $53.99 484.45K
Q2 2021 share Decrease -25.00% -322.96K shares 5.78M $33.44 968.90K
Q1 2021 share 0.00% 0 shares 3.97M $20.6 1.29M
Q4 2020 share Decrease -25.00% -430.62K shares -2.91M $17.52 1.29M
Q3 2020 share Increase +7.66% 122.5K shares 4.74M $14.83 1.72M
Q2 2020 share Increase 0.00% 1.6M shares 20.8M $13 1.6M